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Background
Adherence to colonoscopy recommendations can reduce
colorectal cancer (CRC) morbidity and mortality. How-
ever, little is known about the use of colonoscopy among
persons at risk for Lynch syndrome prior to clinical
genetic testing (CGT) and how notification of mutation
carrier status affects screening behaviors. The goal of this
study was to evaluate colonoscopy use and attitudes
towards CRC screening among unaffected relatives of
Lynch syndrome mutation carriers before pre-test genetic
counseling (baseline) and 6 and 12 months after disclosure
of the test results. The primary outcomes of interest were
colonoscopy utilization, commitment to screening for
colonoscopy, self-efficacy regarding screening adherence,
and the benefits, barriers, and efficacy of CRC screening.
Methods
110 unaffected relatives completed a psychosocial ques-
tionnaire prior to pre-test counseling, 81 had GCT and
received test results, and 78 subsequently completed fol-
low-up questionnaires at 6 and 12 months post-results
disclosure (52 were mutation negative and 26 were muta-
tion positive). Linear mixed models were used to evaluate
group comparisons in change over time. In addition to
the main effects of mutation status and time, the time by
mutation interactions were included as fixed effects in
the model to test for differences in average rate of change
over time between the two mutation groups.
Results
While both groups were similar at baseline, after disclo-
sure of results, a significantly greater number of those
with a positive test result had a colonoscopy compared
with persons who tested negative where colonoscopy
utilization decreased significantly (Figure 1).
Analysis showed a significant positive movement
through the stages of readiness to have colonoscopy in
the mutation-positive group from baseline to 6 and
12 month post-disclosure compared to a significant
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Figure 1 Percent Colonoscopy at Baseline and 6 and 12 Months
after Disclosure of Lynch Syndrome Genetic Test Results.
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the mutation negative group (Table 1). Analysis showed
a significant increase in self-efficacy and benefits of CRC
screening in the mutation-positive group from baseline
to 6 and 12 month post-disclosure and no difference in
the mutation-negative group. There was a significant
decrease in barriers to CRC screening in the mutation-
positive group from baseline to 6 and 12 month post-
disclosure and no difference in the mutation-negative
group (Table 1).
Conclusion
Our results show that CGT may motivate mutation car-
riers to have a colonoscopy after receiving test results
and may also have an impact on their longer-term
screening behaviors. In addition, CGT may have a posi-
tive impact on mutation carriers’ attitudes towards CRC
screening.
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Table 1 Comparison of psychosocial measures by test result at baseline, 6 months post-results disclosure, and
12 months post-results disclosure (n=78)
Positive (n=26) Negative (n=52)
Baseline M (SD) 6 months M (SD) 12 months M (SD) Baseline M (SD) 6 months M (SD) 12 months M(SD)
Readiness (% committed) 58% 81%* 88%* 69% 51% 62%
Self-efficacy 85% (28) 96% (8)* 96% (11)* 89% (22) 90% (19) 87% (25)
Benefits 4.4 (0.6) 4.6 (0.5)* 4.8 (0.4)* 4.4 (0.6) 4.5 (0.5) 4.5 (0.6)
Barriers 2.7 (0.6) 2.3 (0.7)* 2.7 (0.6)* 2.3 (0.7)* 2.3 (0.7) 2.2 (0.7)
Efficacy 4.1 (0.4) 4.3 (0.5) 4.3 (0.5) 4.1 (0.7) 4.1 (0.6) 4.1 (0.6)
* p<.05.
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